Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bobby Bhasker-Rao

Surgery Rancho Mirage, CA Medical Doctor

NPI 1154409290 CMS profile 823013

35900 Bob Hope Dr, Suite 205, Rancho Mirage, CA 92270

Open in the dashboard

General payments

$305,622

483 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bobby Bhasker-Rao of Rancho Mirage, CA is reported in the CMS Open Payments database as having received $305,622 across 483 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,938 16
2024 General $23,311 42
2023 General $7,320 22
2022 General $8,880 64
2021 General $100,974 109
2020 General $60,182 79
2019 General $100,016 151

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bobby Bhasker-Rao
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Bobby Bhasker-Rao were reported at $4,938. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Bobby Bhasker-Rao Surgery median Middle half National median
2019 $100,016 $253 $82–$1,521 $163
2020 $60,182 $131 $40–$706 $114
2021 $100,974 $168 $50–$904 $132
2022 $8,880 $224 $76–$1,218 $149
2023 $7,320 $253 $82–$1,255 $160
2024 $23,311 $279 $90–$1,381 $164
2025 $4,938 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $301,557 399 payments
  2. Medtronic, Inc. $1,559 18 payments
  3. Covidien LP $459 12 payments
  4. Daiichi Sankyo Inc. $446 23 payments
  5. Standard Bariatrics, Inc. $359 8 payments
  6. Teleflex LLC $291 4 payments
  7. Endogastric Solutions, Inc $219 3 payments
  8. Davol Inc. $158 2 payments
  9. Suture Ease, Inc. $138 1 payment
  10. CONMED Corporation $106 1 payment
  11. Other $330 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $240,675 96 payments
  2. Travel and Lodging $29,536 168 payments
  3. Food and Beverage $18,012 206 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $17,391 12 payments
  5. Gift $9 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $295,557 397 payments
  2. DAVINCI XI $6,000 2 payments
  3. Signia $900 10 payments
  4. INJECTAFER $430 22 payments
  5. LigaSure $425 5 payments
  6. TITAN SGS STANDARD GASTRIC STAPLER Bariatric Surgery $359 8 payments
  7. EsophyX $219 3 payments
  8. ARISTA AH FlexiTip $158 2 payments
  9. Titan SGS Standard Gastric Stapler Surgical $141 1 payment
  10. Endo GIA $129 4 payments
  11. Other $773 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 13 billing codes

Paid by Medicare

$19,138

Medicare's payments for the services billed

Medicare patients

51

Average age 65

Services billed

72

39 women, 12 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Diabetes 61%
Depression 53%
COPD 24%
Ischemic heart disease 22%
Chronic kidney disease 22%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
INJECTAFER
  • Daiichi Sankyo Inc. $163
$163 — —
Wegovy
  • Novo Nordisk Inc $17
$17 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

483 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record